HBIO vs ICCC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

HBIO

35.3
AI Score
VS
ICCC Wins

ICCC

68.5
AI Score

Investment Advisor Scores

HBIO

35score
Recommendation
SELL

ICCC

69score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HBIO ICCC Winner
Revenue 43.48M 17.54M HBIO
Net Income -6.33M 3.78M ICCC
Gross Margin 57.2% 40.4% HBIO
Net Margin -14.6% 21.5% ICCC
Operating Income -2.15M 3.90M ICCC
ROE -85.4% 12.0% ICCC
ROA -8.3% 8.1% ICCC
Total Assets 76.29M 46.63M HBIO
Cash 6.50M 8.86M ICCC
Debt/Equity 4.94 0.26 ICCC
Current Ratio 1.87 4.75 ICCC
Free Cash Flow -1.45M 5.68M ICCC

Relative Price Performance (Last 90 Days)

HBIO 1M: +30.1% · 3M: +20.9% ICCC 1M: -10.3% · 3M: +1.1%

Current Technical Phase

HBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.0% over 20 days), RSI 67

RSI (14): 66.5 · Price: $8.03

ICCC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.4 · Price: $9.85

Fundamentals Snapshot

Metric HBIO ICCC
Market Cap
Forward P/E 12.5 0.0
Trailing P/E 141.6
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.6% 0.4%
Operating Margin 0.0% 0.3%
EPS -2.36 0.07
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICCC is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.